ADAMTS13 recovery in caplacizumab-treated TTP

被引:0
|
作者
Laemmle, Bernhard [1 ,2 ]
机构
[1] Univ Bern, Bern, Switzerland
[2] Univ Med Ctr Mainz, Mainz, Germany
关键词
D O I
10.1182/blood.2024023862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1785 / 1786
页数:2
相关论文
共 50 条
  • [21] Adamts13 levels in HIV infected patients with and without TTP
    Meiring, M.
    Van Staden, B.
    Van Hoorelbeke, K.
    Deckmyn, H.
    Badenhorst, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 874 - 874
  • [22] A Case of TTP in a Patient with MCTD and Elevated ADAMTS13 Antibodies
    Pittman, Natalia
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1186 - 1186
  • [23] Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors
    Upreti, Harshvardhan
    Kasmani, Jamil
    Dane, Kathryn
    Braunstein, Evan M.
    Streiff, Michael B.
    Shanbhag, Satish
    Moliterno, Alison R.
    Sperati, C. John
    Gottesman, Rebecca F.
    Brodsky, Robert A.
    Kickler, Thomas S.
    Chaturvedi, Shruti
    BLOOD, 2019, 134 (13) : 1037 - 1045
  • [24] The predictive value of ADAMTS13 activity for treatment monitoring of patients with acquired TTP: data from the phase II TITAN trial with caplacizumab
    Callewaert, F.
    Ulrichts, H.
    Hovinga, Kremer J. A.
    De Swert, K.
    Tersago, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 234 - 235
  • [25] ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
    Voelker, Linus A.
    Kaufeld, Jessica
    Miesbach, Wolfgang
    Braehler, Sebastian
    Reinhardt, Martin
    Kuehne, Lucas
    Muehlfeld, Anja
    Schreiber, Adrian
    Gaedeke, Jens
    Toelle, Markus
    Jabs, Wolfram J.
    Ozcan, Fedai
    Markau, Silke
    Girndt, Matthias
    Bauer, Frederic
    Westhoff, Timm H.
    Felten, Helmut
    Hausberg, Martin
    Brand, Marcus
    Gerth, Jens
    Bieringer, Markus
    Bommer, Martin
    Zschiedrich, Stefan
    Schneider, Johanna
    Elitok, Saban
    Gawlik, Alexander
    Gaeckler, Anja
    Kribben, Andreas
    Schwenger, Vedat
    Schoenermarck, Ulf
    Roeder, Maximilian
    Radermacher, Joerg
    Bramstedt, Joern
    Morgner, Anke
    Herbst, Regina
    Harth, Ana
    Potthoff, Sebastian A.
    von Auer, Charis
    Wendt, Ralph
    Christ, Hildegard
    Brinkkoetter, Paul T.
    Menne, Jan
    BLOOD ADVANCES, 2020, 4 (13) : 3093 - 3101
  • [26] The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction
    Austin, S. K.
    Starke, R. D.
    Lawrie, A. S.
    Cohen, H.
    Machin, S. J.
    Mackie, I. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) : 536 - 544
  • [27] ADAMTS13 antigen levels in 7 TTP patients studied longitudinally
    Starke, R
    Machin, S
    Scully, M
    Purdy, G
    Mackie, I
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 48 - 48
  • [28] FXI/ADAMTS13 complex in TTP and factor XI deficient patients
    Starke, Richard
    Mackie, Ian
    Lawrie, Andrew
    Scully, Marie
    Machin, Samuel
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 77 - 77
  • [29] NOVEL ADAMTS13 MUTATION IN A PATIENT WITH HEREDITARY TTP TREATED WITH PLASMA-DERIVED FACTOR VIII
    Hurley, Rachel
    Wyatt, Kirk
    Coon, Lea
    Kohorst, Mira
    van Dorland, Hendrika
    Arndt, Carola
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [30] ADAMTS13 in nephrology [ADAMTS13 in der Nephrologie]
    Bockmeyer C.L.
    Modde F.
    Becker J.U.
    Der Nephrologe, 2013, 8 (1): : 69 - 70